BIVDA has issued a Press Release on the MHRA's decision to grant exceptional use authorisation for NHS Test and Trace's self-testing device. 

BIVDA Chief Operating Officer – Helen Dent said;

“We welcome the exceptional use authorisation for this self-test device to be used as part of the wider strategy to test for and control COVID-19, but emphasise that this is part of the solution and other methods and laboratory tests remain vital.

This technology has a specific use and therefore specific limitations, and as such BIVDA members will continue to support the NHS Test and Trace system with the provision of multiple test types to combat this virus.”